Targeting UDP-Galactopyranose Mutases From Eukaryotic Human Pathogens

Current Pharmaceutical Design - United Arab Emirates
doi 10.2174/1381612811319140007
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Bentham Science Publishers Ltd.

Related search

Antimicrobial Compounds From Eukaryotic Microalgae Against Human Pathogens and Diseases in Aquaculture

Marine Drugs
Drug Discovery
2016English

In Crystallo Capture of a Covalent Intermediate in the UDP-Galactopyranose Mutase Reaction

English

Investigation of Binding of UDP-Galfand UDP-[3-F]Galfto UDP-galactopyranose Mutase by STD-NMR Spectroscopy, Molecular Dynamics, and CORCEMA-ST Calculations†

Journal of the American Chemical Society
BiochemistryColloidCatalysisChemistrySurface Chemistry
2008English

Investigation of Binding of UDP-Galf and UDP-[3-F]Galf to UDP-galactopyranose Mutase by STD-NMR Spectroscopy, Molecular Dynamics, and CORCEMA-ST Calculations

English

Purification, Crystallization and Preliminary X-Ray Diffraction Data of UDP-galactopyranose Mutase fromAspergillus Fumigatus

Acta Crystallographica Section F Structural Biology and Crystallization Communications
2012English

Structural Basis of Ligand Binding to UDP-Galactopyranose Mutase fromMycobacterium tuberculosisUsing Substrate and Tetrafluorinated Substrate Analogues

Journal of the American Chemical Society
BiochemistryColloidCatalysisChemistrySurface Chemistry
2015English

Crystal Structures of Acetate Kinases From the Eukaryotic Pathogens Entamoeba Histolytica and Cryptococcus Neoformans

Journal of Structural Biology
Structural Biology
2013English

Thrombin-Promoted Release of UDP-glucose From Human Astrocytoma Cells

British Journal of Pharmacology
Pharmacology
2009English

Human UDP-galactose 4-Epimerase

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2001English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy